Albany, NY -- (SBWIRE) -- 10/18/2016 -- Increasing preference for collagen products is attributed to expanding applications supported by several benefits such as easy availability and low antigenicity. In addition, collagen represents one of the abundant proteins found in animals. Currently, around 28 types of collagen are present in nature; however, three major types (type I, II, and III) of collagen account for around 80% to 90% of the total body collagen composition. Collagen, a part of connective tissue, finds application across various industries such as food & beverage, pharmaceutical, cosmeceuticals, and nutraceuticals. The suitable use of collagen across industries is majorly dependent on characteristics such as antigenicity, tensile strength, and grade of the collagen.
Rising awareness about personal health and rigorous research and development efforts by the market players toward development of novel collagen-based products are the key drivers of the collagen market. In addition, extensive usage of collagen products in wound healing applications is likely to fuel market growth. Increasing geriatric population creates an indirect demand for collagen and collagen-based products. For instance, rising geriatric population leads to increased usage of collagen-based products, especially in skincare, bone and joint health, and for wound healing. Moreover, according to the United Nations report on "World Population Ageing", the number of people aged 60 years and above across the world is projected to increase by 56% from 901 million in 2015 to 1.4 billion 2030.
Complete Report with TOC @ http://www.mrrse.com/collagen-market
Bovine, porcine, and marine sources comprise major sources of collagen, while chicken, ovine, equine, and silkworms constitute other potential sources of collagen. Bovine collagen source is one of the major industrial sources of collagen; however, usage of bovine collagen source is likely to decline during the forecast period owing to high probability of disease transmission. Bovine spongiform encephalopathy (BSE), mad cow disease, and transmissible spongiform encephalopathy (TSE) constitute some of the diseases that pose a threat to humans. Similarly, the porcine collagen source segment accounted for the largest share of the market in 2014. However, negative cultural impact and allergic reactions are likely to hamper market growth. Marine collagen source has been identified to be the safest collagen source as compared to conventional sources owing to greater absorption and low molecular weight, among other benefits. The segment is expected to record highest growth rate during the forecast period from 2015 to 2023. Chicken, ovine, equine, and silk worms represent other sources of collagen.
The tissue engineering application segment is anticipated to exhibit highest growth rate during the forecast period as the use of collagen type I is considered a gold standard in tissue engineering owing to its high biocompatibility. Some of the collagen-based biomaterials used in tissue engineering are scaffolds for bone regeneration and injectable matrices. Furthermore, collagen-based drug delivery systems accounted for the major share of the collagen application market. This is attributed to extensive use of collagen-based products in wound healing, and increasing use of collagen as wound dressings either in the form of collagen sponges or collagen films for wounds and burns, respectively. In addition, introduction of novel drug delivery systems such as nanoparticles-based drug delivery systems is anticipated to support the growth of the collagen market.
North America and Europe accounted for a major share of the collagen market in 2014 due to increased uptake and awareness about collagen and its benefits. Additionally, increasing geriatric population is likely to accelerate the indirect demand for collagen-based products. Furthermore, presence of well-established manufacturing facilities and rigorous research activities toward development of novel collagen-based products is likely to boost market growth in these regions.
Free Sample Copy of the Report @ http://www.mrrse.com/sample/1698
The collagen market in Asia Pacific is anticipated to record the highest growth rate during the forecast period owing to increasing affordability and implementation of favorable government regulations. In addition, rapid industrialization, increasing awareness about personal health, and growing pharmaceutical industry are expected fuel market growth. Latin America is anticipated to record the second highest growth rate from 2015 to 2023.
The collagen market has been dominated by few leading players such as Collagen Solutions plc, Collagen Matrix, Inc., EternoGen LLC, Medtronic plc, Kyeron B.V., and Nippi, Inc. Several other mid and small sized collagen companies are gaining importance as they form strategic alliances with established players for certain activities. In addition, increasing trend of strategic partnerships of biopharmaceutical and medical device companies with these companies is anticipated to support market growth during the forecast period from 2015 to 2023.
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.